You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and Neck Squamous Cell Carcinoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

Active, not recruiting
  • Cancer of Head and Neck
  • +5 more
  • MK-3475 (neoadjuvant)
  • +6 more
  • Boston, Massachusetts
  • +2 more
Dec 9, 2022

Acupuncture on Acute Dysphagia in Patients Treated With

Recruiting
  • Head and Neck Squamous Cell Carcinoma
    • Florence, Italy
    • +1 more
    Nov 6, 2022

    Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

    Not yet recruiting
    • Head and Neck Cancer
    • +2 more
    • Chicago, Illinois
      University of Chicago Medicine Comprehensive Cancer Center
    Oct 25, 2023

    Advanced Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, MET-4, Placebo)

    Not yet recruiting
    • Advanced Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Feb 22, 2023

    Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

    Not yet recruiting
    • Esophageal Cancer
    • +9 more
    • (no location specified)
    Feb 2, 2023

    Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

    Recruiting
    • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • +4 more
    • Cemiplimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 17, 2023

    Regional Nodal Basins and Gene Expression Profiling in Primary

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • Ultrasound
    • 40-GEP
    • (no location specified)
    Jul 12, 2023

    Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

    Not yet recruiting
    • Head and Neck Neoplasms
    • TransCon TLR7/8 Agonist
    • +2 more
    • (no location specified)
    Aug 4, 2023

    Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Dec 20, 2022

    Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +2 more
    • RP3
    • +3 more
    • (no location specified)
    Feb 21, 2023

    Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Neck Dissection
    • Elective neck dissection
    • Therapeutic neck dissection
    • (no location specified)
    Apr 10, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (SI-B001, SI-B003)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Shanghai, Shanghai, China
      Shanghai Oriental Hospital
    Jan 13, 2023

    Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

    Active, not recruiting
    Has Results
    • Squamous Cell Carcinoma of the Oropharynx
    • +7 more
    • Tampa, Florida
    • +2 more
    Dec 30, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Camrelizumab+cetuximab+chemo)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Shanghai, China
      Fudan University
    Jan 4, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • dose-reduced radiotherapy
    • Zhuhai, Guangdong, China
      Fifth Affiliated Hospital of Sun Yat-sen University
    May 3, 2023

    Head and Neck Squamous Cell Carcinoma Trial (MRI)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • MRI
    • (no location specified)
    Jun 21, 2023

    Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla (Ibrutinib 560mg PO daily (Imbruvica),

    Active, not recruiting
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of the Head and Neck
    • Ibrutinib 560mg PO daily (Imbruvica)
    • +2 more
    • La Jolla, California
      UCSD Moores Cancer Center
    Jan 11, 2023

    Squamous Cell Carcinoma of the Head and Neck, Paclitaxel, Carboplatin Trial in Amiens (GCP intratumoral catheter)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • +3 more
    • intratumoral catheter
    • Amiens, Picardie, France
      CHU Amiens Picardie
    Apr 26, 2023

    Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

    Recruiting
    • Squamous Cell Carcinoma of Oral Cavity
    • +3 more
    • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
    • Gliwice, Silesia, Poland
      The Maria Sklodowska-Curie National Research Institute of Oncolo
    Aug 7, 2023

    Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy

    Suspended
    • Resectable Head and Neck Squamous Cell Carcinoma
    • 42 Gy Radiation Therapy
    • +2 more
    • Milwaukee, Wisconsin
      Froedtert & the Medical College of Wisconsin
    Jan 13, 2023

    Head Neck Cancer Trial in Charleston (Pembrolizumab, Clopidogrel, acetylsalicylic acid)

    Recruiting
    • Head and Neck Cancer
    • Charleston, South Carolina
      Medical University of South Carolina
    Dec 22, 2022

    Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node

    Recruiting
    • Squamous Cell Carcinoma
    • +2 more
    • sentinel lymph node biopsy (SLNB)
    • Indianapolis, Indiana
      Indiana University Melvin & Bren Simon Cancer Center
    Nov 15, 2022

    Head and Neck Squamous Cell Cancer

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • OncoPrism-HNSCC™
    • San Francisco, California
      Curebase
    Sep 7, 2022

    Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Jul 13, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Villejuif (Nasofibroscopy, Low Dose Chest CTscan, injected CT-scan)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nasofibroscopy
    • +5 more
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Jan 19, 2023